Precursor Lymphoid Neoplasm — Trials

Precursor Lymphoid Neoplasm — Trials · CancerIndex

Clinical trials

Registered studies

2,154 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

Active: 567
Recruiting: 344
Ph III recruiting: 27
Growth YoY: −11.9%
Industry share: 13%
Top sponsor: City of Hope Medical Center
Termination share: 33.1%

Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancers Terminated studies (286)

clinicaltrialsPublishedShowing 51–91 of 91 studies matching the filters · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT02965092	CD19 Chimeric Antigen Receptor (CAR)-Modified T Cell Therapy in Treating Patients With B-cell Malignancies	unknown	Phase 1 / Phase 2	80	Wuhan Sian Medical Technology Co., LtdINDUSTRY	1	May 10, 2019	clinicaltrials
NCT03366350	Anti-CD19 CAR-T Therapy Bridging to HSCT for CD19+ B-Cell Malignancies	unknown	Phase 1 / Phase 2	50	Wuhan Sian Medical Technology Co., LtdINDUSTRY	1	May 10, 2019	clinicaltrials